JONES MITCHELL LAWRENCE (Chief Medical Officer) sold 13.0% of their position (1.99K shares) of PALISADE BIO, INC. on the open market
Open‑market sale worth $3.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/13/2026ACC: 0001493152-26-006833
Officer· Chief Medical Officer
Since Feb 2026
-1.99K
Net shares
Net seller
$3.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
8K acquired · 9.99K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+8K
Price / share
—
Trade value
—
% of position
110.3%
2/11/2026
7.25K→15.25K
Common Stock
Direct
Shares
−1.99K
Price / share
$1.75
Trade value
$3.48K
% of position
13.0%
2/12/2026
15.25K→13.26K
Total
Net shares
+6.01K
Net value
-$3.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/11/2026 | M · Option Exercise | +8K | — | — | 110.3% | 7.25K | 15.25K |
| Common Stock Direct | 2/12/2026 | S · Sale | −1.99K | $1.75 | $3.48K | 13.0% | 15.25K | 13.26K |
| Total | +6.01K | -$3.48K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
8K shares
Shares
−8K
Strike price
Held after
16K
Exercisable
—
2/11/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock8K shares | 2/11/2026 | M · Option Exercise | −8K | — | 16K |